CRMDCorMedix Inc.
$7.31-34% 1Y
$7.31
$6.2552 weeks$12.73
The financials
CorMedix Inc. by the numbers
CorMedix Inc. (CRMD) reported revenue of $102M in Q2 2026 (quarter ended Jun 30, 2026), up 157% from the same quarter a year earlier. That came with a gross margin of 76% and net income of $26M (25% of revenue). For the full year FY2025, revenue was $312M (+617% year on year) and net income $163M. The next results filing is expected around Nov 11, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $102M | $40M | +157% |
| Gross profit | $77M | $38M | +104% |
| Operating income | $43M | $20M | +120% |
| Net income | $26M | $20M | +31% |
| Diluted EPS | $0.29 | $0.28 | +3.6% |